Natco Pharma Ltd has launched a generic version of Tamiflu oral capsules in the US.
This is the first generic equivalent of Tamiflu capsules, the company said in a regulatory filing to the stock exchange on Monday. The company has launched the product, an antiviral medicine used in the treatment of influenza, through its marketing partner Alvogen.
A US registered trademark of Hoffman La-Roche Inc. Corporation, Tamiflu capsules had US sales of around $ 403 million during the 12 months ended December 2015, the Hyderabad-based firm said citing IMS Health figures.
ADVERTISEMENT
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.
This is your last free article.